O'Shaughnessy Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.9M | Buy |
265,158
+26,692
| +11% | +$1.41M | 0.06% | 301 |
|
|
2026
Q1 | $13.2M | Buy |
238,466
+28,313
| +13% | +$1.53M | 0.07% | 321 |
|
|
2025
Q4 | $10.3M | Buy |
210,153
+45,282
| +27% | +$2.11M | 0.06% | 353 |
|
|
2025
Q3 | $7.12M | Sell |
164,871
-8,084
| -5% | -$316K | 0.04% | 410 |
|
|
2025
Q2 | $6.64M | Buy |
172,955
+7,158
| +4% | +$274K | 0.05% | 402 |
|
|
2025
Q1 | $6.42M | Buy |
165,797
+25,521
| +18% | +$934K | 0.05% | 364 |
|
|
2024
Q4 | $4.74M | Sell |
140,276
-32,936
| -19% | -$1.19M | 0.04% | 425 |
|
|
2024
Q3 | $6.78M | Buy |
173,212
+29,974
| +21% | +$1.23M | 0.06% | 328 |
|
|
2024
Q2 | $5.51M | Buy |
143,238
+6,498
| +5% | +$273K | 0.06% | 342 |
|
|
2024
Q1 | $5.86M | Buy |
136,740
+13,201
| +11% | +$544K | 0.06% | 323 |
|
|
2023
Q4 | $4.58M | Sell |
123,539
-4,266
| -3% | -$153K | 0.06% | 328 |
|
|
2023
Q3 | $4.63M | Buy |
127,805
+22,689
| +22% | +$805K | 0.07% | 299 |
|
|
2023
Q2 | $3.75M | Sell |
105,116
-40,527
| -28% | -$1.45M | 0.06% | 327 |
|
|
2023
Q1 | $5.18M | Sell |
145,643
-6,901
| -5% | -$241K | 0.08% | 266 |
|
|
2022
Q4 | $5.36M | Buy |
152,544
+42,924
| +39% | +$1.43M | 0.09% | 250 |
|
|
2022
Q3 | $3.23M | Buy |
109,620
+16,513
| +18% | +$626K | 0.06% | 301 |
|
|
2022
Q2 | $5.07M | Buy |
93,107
+6,127
| +7% | +$338K | 0.09% | 223 |
|
|
2022
Q1 | $4.74M | Buy |
86,980
+17,918
| +26% | +$973K | 0.08% | 259 |
|
|
2021
Q4 | $3.81M | Buy |
69,062
+8,947
| +15% | +$465K | 0.07% | 265 |
|
|
2021
Q3 | $2.87M | Buy |
60,115
+18,174
| +43% | +$913K | 0.06% | 261 |
|
|
2021
Q2 | $2.09M | Buy |
41,941
+8,332
| +25% | +$400K | 0.04% | 303 |
|
|
2021
Q1 | $1.5M | Buy |
33,609
+20,526
| +157% | +$932K | 0.03% | 323 |
|
|
2020
Q4 | $602K | Buy |
13,083
+53
| +0.4% | +$2.44K | 0.02% | 463 |
|
|
2020
Q3 | $613K | Sell |
13,030
-2,405
| -16% | -$120K | 0.02% | 403 |
|
|
2020
Q2 | $787K | Buy |
15,435
+10,659
| +223% | +$547K | 0.02% | 314 |
|
|
2020
Q1 | $226K | Buy |
4,776
+966
| +25% | +$51.5K | 0.01% | 436 |
|
|
2019
Q4 | $224K | Buy |
3,810
+3,804
| +63,400% | +$212K | 0.01% | 590 |
|
|
2019
Q3 | $0 | Buy |
6
+2
| +50% | +$103 | ﹤0.01% | 1084 |
|
|
2019
Q2 | $0 | Buy |
+4
| New | +$201 | ﹤0.01% | 1072 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | – | – | 947 |
|
|
2017
Q3 | $0 | Buy |
+1
| New | +$51 | ﹤0.01% | 936 |
|
|
2017
Q2 | – | Sell |
-138,058
| Closed | -$7.28M | – | 913 |
|
|
2017
Q1 | $7.28M | Buy |
138,058
+5,787
| +4% | +$294K | 0.17% | 87 |
|
|
2016
Q4 | $10.6M | Sell |
132,271
-312,142
| -70% | -$15.4M | 0.25% | 77 |
|
|
2016
Q3 | $24M | Sell |
444,413
-94,585
| -18% | -$5.19M | 0.56% | 50 |
|
|
2016
Q2 | $29.2M | Sell |
538,998
-10,602
| -2% | -$559K | 0.76% | 39 |
|
|
2016
Q1 | $28M | Sell |
549,600
-132,594
| -19% | -$6.6M | 0.7% | 42 |
|
|
2015
Q4 | $34.4M | Sell |
682,194
-122,166
| -15% | -$6.23M | 0.85% | 37 |
|
|
2015
Q3 | $38.7M | Buy |
804,360
+7,518
| +0.9% | +$391K | 0.8% | 36 |
|
|
2015
Q2 | $41.5M | Buy |
796,842
+153,904
| +24% | +$8.67M | 0.84% | 33 |
|
|
2015
Q1 | $37.1M | Buy |
642,938
+136,599
| +27% | +$7.83M | 0.72% | 40 |
|
|
2014
Q4 | $23.6M | Buy |
506,339
+407,555
| +413% | +$22.8M | 0.45% | 62 |
|
|
2014
Q3 | $5.68M | Buy |
+98,784
| New | +$6.06M | 0.1% | 150 |
|
Other funds holding GSK
JEST
O'Shaughnessy Asset Management's GSK Position: Q2 2026 in Review
O'Shaughnessy Asset Management increased its GSK (GSK) stake by 11% in Q2 2026, buying an estimated $1.41M and bringing the position to 265,158 shares worth $13.9M. The position accounts for 0.06% of the portfolio, ranked #301.
O'Shaughnessy Asset Management first reported a position in GSK in Q3 2014 and has held it in 41 quarters since. The position peaked at $41.5M in Q2 2015. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- O'Shaughnessy Asset Management held 265,158 shares of GSK worth $13.9M as of Q2 2026.
- O'Shaughnessy Asset Management bought 26,692 GSK shares in Q2 2026, an estimated $1.41M.
- GSK made up 0.06% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #301 holding.
- O'Shaughnessy Asset Management first reported a position in GSK in Q3 2014 and has held it in 41 quarters since.
- O'Shaughnessy Asset Management's GSK position peaked at $41.5M in Q2 2015.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.